首页> 外国专利> USE OF NKX6.3 FOR PREDICTION OF CANCER OCCURRENCE AND EARLY DIAGNOSIS OF CANCER AND AS THERAPEUTIC AGENT FOR CANCER

USE OF NKX6.3 FOR PREDICTION OF CANCER OCCURRENCE AND EARLY DIAGNOSIS OF CANCER AND AS THERAPEUTIC AGENT FOR CANCER

机译:NKX6.3在预测癌症的发生率和早期诊断中的用途以及作为癌症的治疗剂

摘要

The present invention relates to a use of NKX6.3 for prediction of cancer occurrence and early diagnosis of cancer and as a therapeutic agent for cancer and, more specifically, to a use of NKX6.3 for prediction of cancer occurrence and early diagnosis of cancer on the basis of the expression level of NKX6.3 protein, the expression level of mRNA and the number of DNA copies, and for prevention and treatment of cancer by administrating an NKX6.3 protein or gene. The NKX6.3 according to the present invention can be used as a diagnostic composition for early diagnosis of cancer because the activity or expression thereof is inhibited in a cancer cell. Also, NKX6.3 exerts the functions of inhibiting the survival and proliferation of cancer cells and inducing apoptosis when the expression thereof is induced, and thus can be usefully used as a composition for anti-cancer treatment.
机译:NKX6.3在癌症的预测和癌症的早期诊断中的用途本发明涉及NKX6.3在癌症的预测和癌症的早期诊断中的用途,并且更具体地涉及NKX6.3在癌症的预测和癌症的早期诊断中的用途。根据NKX6.3蛋白的表达水平,mRNA的表达水平和DNA拷贝数,并通过施用NKX6.3蛋白或基因来预防和治疗癌症。由于本发明的NKX6.3的活性或表达在癌细胞中被抑制,因此可以用作用于癌症的早期诊断的诊断组合物。此外,NKX6.3在诱导其表达时发挥抑制癌细胞的存活和增殖以及诱导细胞凋亡的功能,因此可以有效地用作抗癌治疗用组合物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号